Scandion Oncology A/S announced that the company has strengthened its Clinical Advisory Board with three international highly experienced Key Opinion Leaders in oncology. With Professor Richard Schilsky already on board since April 2021, the Clinical Advisory Board now consists of four members. The three new members are Professor Josep Tabernero, MD, PhD; Professor Eric Van Cutsem, MD, PhD; and Professor Thomas Seufferlein, MD. Josep Tabernero, MD, PhD:Professor and Head of the Medical Oncology Department and Director of the Vall d'Hebron Institute of Oncology (VHIO) in Barcelona. He is a member of the Executive Board of the European Society for Medical Oncology (ESMO) having served as ESMO President in 2018 - 2019. Eric Van Cutsem, MD, PhD:Professor and Division Head of Digestive Oncology at University of Leuven and University Hospitals Gasthuisberg, Leuven, Belgium and is the president of the Belgian Foundation against Cancer. Dr. Van Cutsem has received several awards, amongst others the European Society for Medical Oncology (ESMO) Award in 2019 and the European Awards in Medicine for Cancer Research. Thomas Seufferlein, MD: Professor and Medical Director at the Department of Internal Medicine I and Deputy Director Comprehensive Cancer Center at Ulm University Hospital in Germany. Dr. Seufferlein is a member of several German and European scientific groups and organizations. He is currently President of the German Cancer Society (DKG), chairman of the committee for cancer prevention of the German Cancer Aid (DKH), the steering committee of the German Program for Oncological Guidelines of DKG, DKH and AWMF, and of the certification commission of the DKG-certified colorectal cancer centers.